Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.81
Delayed Data
As of Feb 10
 -0.11 / -2.81%
Today’s Change
3.56
Today|||52-Week Range
28.29
-61.24%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.92
Today’s open3.99
Day’s range3.56 - 4.18
Volume116,910
Average volume (3 months)112,537
Market cap$92.7M
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-12.59%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.04-1.90%
PRQRProQR Therapeutics N...+0.17+4.31%
PETXAratana Therapeutics...+0.07+2.61%
ARGSArgos Therapeutics I...-0.57-12.58%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$24.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
John D. Mendlein
Chief Financial Officer
Stan Blackburn
Corporate headquarters
San Diego, California

Forecasts

Partner Offers